Brain death/death by neurologic criteria determination: an update.


Journal

Current opinion in anaesthesiology
ISSN: 1473-6500
Titre abrégé: Curr Opin Anaesthesiol
Pays: United States
ID NLM: 8813436

Informations de publication

Date de publication:
01 Oct 2022
Historique:
pubmed: 10 8 2022
medline: 9 9 2022
entrez: 9 8 2022
Statut: ppublish

Résumé

Brain death, also known as death by neurologic criteria (DNC), is a well-established concept. In this article, we present a short history of the concept and give an overview of recent changes and a practical update on diagnosis and definitions of brain death/DNC. Unresolved issues will be discussed. There is variability in brain death/DNC determination worldwide. In recent years, successful attempts have been made to harmonize these criteria and, consequently, to improve public trust in the process and diagnosis. An international multidisciplinary collaboration has been created and it has published minimum criteria, provided guidance for professionals and encouragement to revise or develop guidelines on brain death/DNC worldwide. There are two sets of criteria for declaration of death. First, if there is neither cardiac output nor respiratory effort, then cardiopulmonary criteria are used. Second, if both the cerebrum and brainstem have completely and permanently lost all functions, and there is a persistent coma, absent brainstem reflexes and no spontaneous respiratory effort, death can be declared on the basis of brain death/DNC. Although attempts to formulate uniform criteria are ongoing, consensus has been reached on the minimum criteria. Some inconsistencies and questions remain.

Identifiants

pubmed: 35942705
doi: 10.1097/ACO.0000000000001173
pii: 00001503-202210000-00007
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

570-576

Informations de copyright

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Références

Greer DM, Shemie SD, Lewis A, et al. Determination of Brain Death/Death by Neurologic Criteria: The World Brain Death Project. JAMA - J Am Med Assoc 2020; 324:1078–1097.
Lewis A, Liebman J, Bakkar A, et al. Determination of brain death/death by neurologic criteria in countries in Asia and the Pacific. J Clin Neurol 2020; 16:480–490.
Lewis A, Bakkar A, Kreiger-Benson E, et al. Determination of death by neurologic criteria around the world. Neurology 2020; 95:E299–E309.
Bernat JL. How the distinction between “irreversible” and “permanent” illuminates circulatory-respiratory death determination. J Med Philos 2010; 35:242–255.
Dalle Ave AL, Bernat JL. Inconsistencies between the criterion and tests for brain death. J Intensive Care Med 2020; 35:772–780.
Lewis A, Kirschen MP. Brain death/death by neurologic criteria determination. Continuum (Minneap Minn) 2021; 27:1444–1464.
Smith WS. Standardizing brain death globally. JAMA Neurol 2020; 77:1353–1354.
Criteria for the diagnosis of brain stem death. Review by a working group convened by the Royal College of Physicians and endorsed by the Conference of Medical Royal Colleges and their Faculties in the United Kingdom. J R Coll Physicians Lond 1995; 29:381–382.
Walter U, Fernández-Torre JL, Kirschstein T, et al. When is “brainstem death” brain death? The case for ancillary testing in primary infratentorial brain lesion. Clin Neurophysiol 2018; 129:2451–2465.
Saran J, Padubidri JR. Brain stem death - an overview. Med Leg J 2019; 87:18–20.
Spears W, Mian A, Greer D. Brain death: a clinical overview. J Intensive Care 2022; 10:1–16.
Seifi A, Lacci JV, Godoy DA. Incidence of brain death in the United States. Clin Neurol Neurosurg 2020; 195:105885.
Ganesh A, Galetta S. Editors’ note: determination of death by neurologic criteria around the world. Neurology 2021; 96:825.
Zeman A, Wijdicks EFM, Rabinstein AA, et al. The neurologist and Harvard criteria for brain death. Neurology 2011; 39:1–15.
Beecher HK. Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. A definition of irreversible coma. Special communication: report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA Neurol 1968; 205:337–340.
Chua HC, Kwek TK, Morihara H, et al. Brain death: the Asian perspective. Semin Neurol 2015; 35:152–161.
Wijdicks EFM, Varelas NP, Gronseth GS, et al. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010; 74:1911–1918.
Lee J. The brain during life and in adjudicating death: Reduced brain identity of persons as a critique of the neurological criteria of death. Bioethics 2022; 36:628–634.
Chatterjee K, Rady MY, Verheijde JL, et al. A Framework for revisiting brain death: evaluating awareness and attitudes toward the neuroscientific and ethical debate around the American Academy of Neurology Brain Death Criteria. J Intensive Care Med 2021; 36:1149–1166.
White WG. Reflections on the linacre quarterly issue on brain death. Linacre Q 2020; 87:341–346.
Grzonka P, Tisljar K, Rüegg S, Marsch S, et al. What to exclude when brain death is suspected. J Crit Care 2019; 53:212–217.
Murphy L, Wolfer H, Hendrickson RG. Toxicologic confounders of brain death determination: a narrative review. Neurocrit Care 2021; 34:1072–1089.
Ghose K, Holmes KM, Matthewson K. Complications of baclofen overdosage. Postgrad Med J 1980; 56:865–867.
MacHado C, Pérez-Nellar J, Estevez M, et al. Evidence-based guideline update: determining brain death in adults: report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2011; 76:307.
Nakagawa TA, Ashwal S, Mathur M, et al. Clinical report - guidelines for the determination of brain death in infants and children: an update of the 1987 task force recommendations. Pediatrics 2011; 128:e720–e740.
Wijdicks E, Varelas PN, Gronseth GS, et al. Evidence-based guideline update: determining brain death in adults. Neurology 2010; 74:1911–1918.
Shemie SD, Hornby L, Baker A, et al. International guideline development for the determination of death. Intensive Care Med 2014; 40:788–797.
Lewis A, Liebman J, Kreiger-Benson E, et al. Ancillary testing for determination of death by neurologic criteria around the world. Neurocrit Care 2021; 34:473–484.
Marchand AJ, Seguin P, Malledant Y, et al. Revised CT angiography venous score with consideration of infratentorial circulation value for diagnosing brain death. Ann Intensive Care 2016; 6:88.
Bohatyrewicz R, Pastuszka J, Walas W, et al. Implementation of computed tomography angiography (Cta) and computed tomography perfusion (ctp) in polish guidelines for determination of cerebral circulatory arrest (cca) during brain death/death by neurological criteria (bd/dnc) diagnosis procedure. J Clin Med 2021; 10:4237.
Truog RD. Defining death: lessons from the case of jahi McMath. Pediatrics 2020; 146:S75–S80.
Truog RD. Brain death - moving beyond consistency in the diagnostic criteria. JAMA - J Am Med Assoc 2020; 324:1045–1047.
Lewis A, Kumpfbeck A, Liebman J, et al. Barriers to the use of neurologic criteria to declare death in Africa. Am J Hosp Palliat Med 2022; 39:243–249.
Wijdicks EFM. The transatlantic divide over brain death determination and the debate. Brain 2012; 135:1321–1331.
Nair-Collins M, Miller FG. Current practice diagnosing brain death is not consistent with legal statutes requiring the absence of all brain function. J Intensive Care Med 2022; 37:153–156.
US Government Printing Office: United States President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Biobehavioral Research. Defining Death: A Report on the Medical, Legal and Ethical Issues in the Determination of Death. 1981.
Nguyen D. Does the uniform determination of death act need to be revised? Linacre Q 2020; 87:317–333.
Lewis A. The uniform determination of death act is being revised. Neurocrit Care 2022; 36:335–338.

Auteurs

Gea Drost (G)

University of Groningen, Department of Neurology and Neurosurgery, University Medical Center Groningen, Groningen, The Netherlands.

Anthony R Absalom (AR)

University of Groningen, Department of Anesthesiology, University Medical Center Groningen, Groningen, The Netherlands.

Michael A Kuiper (MA)

Department of Intensive Care, Medical Center Leeuwarden, Leeuwarden.
Dutch Transplant Foundation, Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH